Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? (vol 15, 1398859, 2024)FRONTIERS IN PSYCHIATRYIF3.22024-10-280OAAI
Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression (vol 17,1267647,2023)FRONTIERS IN NEUROSCIENCEIF3.22024-10-230OAAI
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?FRONTIERS IN PSYCHIATRYIF3.22024-04-291OAAI
Transcranial magnetic stimulation and ketamine: implications for combined treatment in depressionFRONTIERS IN NEUROSCIENCEIF3.22023-10-266OAAI
Pain perception and response to others pain depends on sensory processing sensitivityEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis抗精神病药对首发精神病患者细胞因子水平影响的Meta分析JOURNAL OF CLINICAL MEDICINEIF2.92021-06-0455OAAI
Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysisPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92018-01-01173PREAI
Functional and Structural Neuroplasticity Induced by Short-Term Tactile Training Based on Braille ReadingFRONTIERS IN NEUROSCIENCEIF3.22016-10-1337OAAI